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Stability of the serum samples after 6 months interval Fisher. Kapton FPC film (127 mM thick) was purchased from American Durafilm. The poly(dimethoxy)silane (PDMS) kit was purchased from Dow Corning. MyOne tosylactivated beads (1 µm diameter, Dynabeads) and were from Invitrogen. Immunoreagents (monoclonal antibodies, polyclonal antibodies, BSA) were dissolved in pH 7.4 phosphate saline buffer (PBS, 5.9 mM Na 2 HPO 4 , 3.9 mM NaH 2 PO 4 , 2.7 mM KCL, 120 mM NaCl). 400 mM EDC and 100 mM NHSS were dissolved in water immediately before use. All solutions were prepared with 18
MΩ·cm water purified through use of a Hydro water purification system (Durham, NC, USA).
PTHrP peptides and Antibodies
Intact PTHrP 1-173 was produced from cDNA encoding the PTHrP 1-173 isoform. and found highly specific with no cross reactivity with PTH and other unrelated peptides. 1 The bioactivity of these monoclonal antibodies was tested previously both in vitro and in vivo.
Polyclonal antibodies against human PTHrP 1-173 (IgY lots 3103 and 3104 were raised in chicken and purified commercially (Genway Biotech, San Diego, CA). The peptides and antibodies were stable for 12 months. On assay days, one vial of 50 pmol/L peptide standard was then diluted to 1 pmol/L followed by serial dilution in 5x diluted calf serum in PBS buffer pH 7.4. The diluted standards were used the same day they were prepared and any left-over standards were discarded. In all the calibration curves 5x diluted calf serum was employed as assay diluent for serial dilutions. Current density was used for quantitation of the standards. The peak height (I, nA) was divided by the surface area of the electrode to yield the current density that was plotted against the concentration of the peptide fragments. Log fitting was used to plot the data.
Immunoradiometric assay (IRMA) for PTHrP
We used a commercial PTHrP assay for correlation purposes (PTHrP RUO, Active® 
Human Serum Samples
Human serum samples from 22 healthy subjects and 37 cancer patients with solid tumors were obtained from McGill University Health Center Biorepository. Blood was drawn in regular tubes, tubes put on ice immediately and separated within 60 min, aliquoted and stored at -80 °C prior to assay. No degradation of the serum samples was observed by assaying the samples after 6 months interval. All samples used in this study were acquired under an institutional review board-approved protocol, and informed consent was obtained from all study participants.
5 Table S1 : Stability of the serum samples after 6 months interval
Microfluidic Device
As previously reported by Otieno et al the microfluidic system featured two devices; detection chamber and capture chamber. 
Production of Gold Immunoarrays
Gold Array Fabrication followed previously established protocols by Jensen et al. 3 Gold nanoparticle ink was prepared at 100 mg/mL in toluene and filtered using a 0. 
Array Fabrication
Immunoarrays were fabricated from 4 nm dodecanethiol decorated gold nanoparticles (AuNPs) on Kapton sheet as previously described 3 using Dimatix inkjet materials printer. The inkjet-printed electrode arrays were annealed to drive off the thiol layer and then insulated with (Table S2) . (Table S2) . 5, 6 The number of horseradish peroxidase labels per magnetic beads determined by measuring enzyme activity using 2,2'-Azino-bis(3-Ethylbenzthiazoline-6 Sulfonic Acid) (ABTS) as reactant (Table   S2 ).
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Detection of PTHrP isoforms and their fragments encompassing the N-terminus and CTerminus
The semi-automated microfluidic system was constructed as previously reported 2 ( Figure   1 , main paper) and electrochemical measurements were all done at room temperature with a CHI 1040A eight-channel potentiostat at conditions optimized for high sensitivity and low S/N. The capture and detection chamber were first connected to the microfluidic system and subjected to a and incubation was allowed for 15 mins for Ab 1 on the array to capture the bead conjugate.
Unbound bead conjugate was then washed off by resuming buffer flow.
To perform amperometric measurements, the arrays were further subjected to a flow of buffer containing 1 mM hydroquinone in PBS for 4 mins. The 8 electrodes of the array were then connected to the working electrode leads of a CHI 1040 multi-potentiostat, and the Pt and Ag/AgCl wires were connected to the counter and reference leads, respectively. Amperometric detection was performed at -0.3 V vs Ag/AgCl by injecting a mixture of 1 mM hydroquinone and 0.1 mM hydrogen peroxide into the detection chamber via the sample loop at 100 µL/min.
Hydrogen peroxide activates HRP on the peptide-Ab 2 -MB-HRP conjugates to ferryloxy-HRP, which, in turn oxidizes hydroquinone to benzoquinone. Signal is generated as benzoquinone is reduced through a 2-electron transfer at the electrode surface.
Optimization of Polyclonal and Monoclonal Antibodies
To establish optimal conditions for the assays as well as to improve on both the signal to 
Evaluation of the Assay Performance
Generally robust analytical requirements (linearity, inter-assay precision, intra-assay precision, absence of a carry-over effect) were fulfilled and reproducibility was good. Inter-assay precision was determined by running the same concentration of two standards on different batches of arrays. On the other hand, intra-assay variation was determined by measuring the variation within the 8-electrode array on same batch. In each case, samples were run in triplicate for each run, with two separate runs each day for 5 days. The inter-assay relative precision was <7% and intra-assay precision was <5% (Table S3 ). The Linear dynamic range of the assay was assessed by running peptide standards in 5x diluted calf serum as well as by running human serum samples at different dilutions. The peptide standards gave linear responses from 0.003 to 16 pg/mL (0.15 fmol/L to 7 pmol/L). Each sample was run in triplicate and averaged. The assay 11 limit of detection was established from the signal of the control (5x diluted calf serum) plus 3x the standard deviation of that signal. Correlation plots were used to evaluate the comparison with the referee IRMA method. The microfluidic system was subjected to PBS-T20 wash for 4 mins before and after each standard run to minimize NSB and carry-over effects ( Figure S3 ).
Analytical recovery of the assay was also evaluated by spiking the diluted calf serum with peptide standards. Analytical recovery above 80% was obtained. 
Specificity Assay
Based on the sensitivities observed during single peptide detection, the larger peptide fragments (1-86 & 1-173) were selected for multiplexed detection (Table S4 ). Employing the 8-electrode array, a sandwich assay was build up on the first three electrodes for detection of 1-173 13 using PA104 and IgY3103, the next three electrodes for detection of 1-86 using PA158 and MA45 and the last two electrodes for detection of 1-173 using PA6 and IgY3104 ( Figure S5A ). 
ROC Analysis
Analysis of the patient PTHrP data was also done using Receiver Operating Characteristic (ROC) plots. ROC is commonly used in clinical tests to determine the accuracy of the test and obtain cut-off values in diagnostic tests. In ROC curves, sensitivity (true positive rate) is plotted against 100-specificity (false positive rate) for different cut-off points. Each point on the ROC curve represents a sensitivity/specificity pair corresponding to a particular decision threshold. A test with perfect discrimination has a ROC curve that passes through the upper left corner (100% sensitivity, 100% specificity). 8 Therefore, the closer the ROC curve is to the upper 14 left corner, the higher the overall accuracy of the test. The area under a ROC curve (AUC) quantifies the overall ability of the test to discriminate between those individuals with the disease and those without the disease. A truly perfect test with zero false positives and zero false negatives has an AUC of 1.00.
Using the PTHrP data from the 57 samples, ROC plot had an AUC of 0.96 and 0.94 for PTHrP levels detected using 1-86 fragment and intact 1-173, respectively. 1-86 fragments gave 80% sensitivity and 100% specificity while intact 1-173 gave 82.86% sensitivity and 95.45% specificity. T-tests showed a significant difference between the PTHrP levels in cancer and control samples ( Figure 6 ) (P <0.001). The cut-off value for PTHrP level in cancer vs non-cancer patients was found to be >10.91 pg/mL (1.1 pmol/L) using 1-86 fragment which in agreement with the IRMA results. Figure 4 (main paper).
Electrode Surface Area Calculation
Prior to each immunoassay, each of the bare gold arrays were cleaned in 0.18M sulfuric acid, by applying 20 sweep segments between 1.5 V and -0.2 V at 100 mV s -1 . Figure 7 shows similar peaks to those found from bulk gold with formation of gold oxide at +1.2 V and reduction back to bulk gold occurring at 0.9 V. 9 From these CVs, the active surface area was calculated following Trasatti et al. 
